, Item 1A Risk Factors, Item 3 Legal Proceedings, Item 7 Managements Discussion and Analysis of Financial Condition and Results of Operations and elsewhere in this annual report and in other reports that we file with the Securities and Exchange Commission. Any forward-looking statement in this annual report is based on information currently available to us and speaks only as of the date of this report. We do not undertake any responsibility to release publicly any revisions to these forward-look...
Q2 FY2026 — expected 2026-08-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-02 | 2025-12-31 | 0001628280-26-013337 | EDGAR | 65K words |
| 2025-03-03 | 2024-12-31 | 0001628280-25-009481 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0001628280-24-008035 | EDGAR | — |
| 2023-03-01 | 2022-12-31 | 0000790526-23-000003 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0000790526-22-000006 | EDGAR | — |
| 2021-03-16 | 2020-12-31 | 0000790526-21-000009 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0000790526-20-000003 | EDGAR | — |
| 2019-03-18 | 2018-12-31 | 0001628280-19-003087 | EDGAR | — |
| 2018-03-19 | 2017-12-31 | 0001683168-18-000705 | EDGAR | — |
| 2017-03-17 | 2016-12-31 | 0001683168-17-000586 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0000790526-25-000008 | EDGAR | 30K words |
| 2025-08-11 | 2025-06-30 | 0001628280-25-039605 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001628280-25-024672 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001628280-24-047285 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0001628280-24-036466 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001628280-24-022619 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001628280-23-038345 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0000790526-23-000014 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0000790526-23-000010 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0000790526-22-000018 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0000790526-22-000015 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0000790526-22-000010 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-02 | 0001683168-26-001385 | EDGAR | 10K words |
| 2026-03-02 | 0001683168-26-001384 | EDGAR | — |
| 2026-01-30 | 0001683168-26-000636 | EDGAR | — |
| 2026-01-09 | 0001683168-26-000190 | EDGAR | — |
| 2025-12-04 | 0001683168-25-008900 | EDGAR | — |
| 2025-11-10 | 0001683168-25-008100 | EDGAR | — |
| 2025-10-21 | 0001683168-25-007694 | EDGAR | — |
| 2025-08-11 | 0001683168-25-005844 | EDGAR | — |
| 2025-07-17 | 0001683168-25-005180 | EDGAR | — |
| 2025-06-12 | 0001683168-25-004440 | EDGAR | — |
247 total filings indexed. 215 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000790526 |
| Ticker | RDNT |
| Exchange | Nasdaq |
| SIC | 8071: Services-Medical Laboratories |
| Incorporated | DE |
| Website | https://www.radnet.com |
| Listed | 1994-10-31 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report